NCT02188368 2023-11-03Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma PatientsOncotherapeuticsPhase 2 Terminated45 enrolled
NCT01991210 2017-08-21A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)Genentech, Inc.Phase 2 Terminated95 enrolled